Insider Analysis From Pillsbury Winthrop Shaw Pittman LLP: The Importance of “Who” in Medical Product Regulation (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
How the Outlooks of Individual Regulators Affect Performance, Compliance and Enforcement
You may also be interested in...
China Arrests Five SFDA Officials On Bribery Charges
SHANGHAI - Chinese authorities earlier this month arrested five officials from the State FDA and the National Institute for the Control of Pharmaceutical and Biological Products for taking bribes, according to reports by the government-run Xinhua News Agency
China Arrests Five SFDA Officials On Bribery Charges
SHANGHAI - Chinese authorities earlier this month arrested five officials from the State FDA and the National Institute for the Control of Pharmaceutical and Biological Products for taking bribes, according to reports by the government-run Xinhua News Agency
Insider Analysis From Pillsbury Winthrop Shaw Pittman LLP: The Importance of “Who” in Medical Product Regulation (Part 2 of 2)
How the Outlooks of Individual Regulators Affect Performance, Compliance and Enforcement